Profilo
Vasily Andrianov worked as the VP-Clinical Development & Medical Affairs at Inhibrx, Inc. from 2021 to 2024.
He holds a doctorate degree from Pavlov First Saint Petersburg State Medical University.
Precedenti posizioni note di Vasily Andrianov
| Società | Posizione | Fine |
|---|---|---|
| INHIBRX, INC. | Direttore Tecnico/Scientifico/R&S | 30/05/2024 |
Formazione di Vasily Andrianov
| Pavlov First Saint Petersburg State Medical University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- Vasily Andrianov
